Shenzhen Edge Medical Co., Ltd. (HKG:2675)

Hong Kong · Delayed Price · Currency is HKD

40.72

+0.80 (2.00%)

Jul 10, 2026, 4:08 PM HKT

-30.98% (1Y)

Market Cap	15.96B
Revenue (ttm)	507.12M +184.8%
Net Income	-98.60M
EPS	-0.27
Shares Out	391.88M
PE Ratio	n/a
Forward PE	217.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	467,500
Open	40.38
Previous Close	39.92
Day's Range	39.20 - 41.88
52-Week Range	33.62 - 73.70
Beta	n/a
Analysts	Buy
Price Target	80.92 (+98.53%)
Earnings Date	Sep 24, 2026

About Shenzhen Edge Medical

Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. The company focus on surgical robots and instruments for minimally invasive surgery or MIS, including multi-port endoscopic surgical robots and single-port endoscopic surgical robots. Its products include Edge Multi-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS using robotic, imaging, and digital technologies; Edge Single-Port Endoscopic Surgical Robot, a robot-assisted devic... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 602

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2675

Full Company Profile

Financial Performance

In 2025, Shenzhen Edge Medical's revenue was 455.72 million, an increase of 184.83% compared to the previous year's 159.99 million. Losses were -88.61 million, -59.45% less than in 2024.

Financial numbers in CNY Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 2675 stock is "Buy." The 12-month stock price target is $80.92, which is an increase of 98.53% from the latest price.

Price Target

$80.92

(98.53% upside)

Analyst Consensus: Buy

Stock Forecasts